These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4727362)

  • 21. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of the specificities of xanthine oxidase and aldehyde oxidase.
    Krenitsky TA; Neil SM; Elion GB; Hitchings GH
    Arch Biochem Biophys; 1972 Jun; 150(2):585-99. PubMed ID: 5044040
    [No Abstract]   [Full Text] [Related]  

  • 23. Pyrazoles and pyrazolo[3,4-d]pyrimidines as biologically active agents.
    Ram VJ; Pandey HN; Mishra L
    Arch Pharm (Weinheim); 1979 Jul; 312(7):586-90. PubMed ID: 496579
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
    Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidation of 4-hydroxypyrazolo (3,4-d) pyrimidine by xanthine oxidase, the route of electron transfer from substrate to acceptor dyes.
    Spector T; Johns DG
    Biochem Biophys Res Commun; 1968 Sep; 32(6):1039-44. PubMed ID: 5750222
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.
    Chauhan M; Kumar R
    Bioorg Med Chem; 2013 Sep; 21(18):5657-68. PubMed ID: 23932070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel pyrazolo[3,4-d]pyrimidine derivatives as potential anti-breast cancer agents.
    Abd El Hamid MK; Mihovilovic MD; El-Nassan HB
    Eur J Med Chem; 2012 Nov; 57():323-8. PubMed ID: 23085106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and bioevaluation of 2-mercapto-6-phenylpyrimidine-4-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
    Shi A; Zhang L; Wang H; Wang S; Yang M; Guan Q; Bao K; Zhang W
    Eur J Med Chem; 2018 Jul; 155():590-595. PubMed ID: 29920453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
    Gatta F; Gradoni L; Lupardini E; Gramiccia M; Orsini S
    Farmaco; 1991 Jan; 46(1):75-84. PubMed ID: 2054043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cow's milk xanthine oxidase by flavonoids.
    Hayashi T; Sawa K; Kawasaki M; Arisawa M; Shimizu M; Morita N
    J Nat Prod; 1988; 51(2):345-8. PubMed ID: 3379415
    [No Abstract]   [Full Text] [Related]  

  • 31. Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
    Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Plescia S; Cusimano MG
    Arch Pharm (Weinheim); 2009 Jun; 342(6):321-6. PubMed ID: 19479756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of pyrazolo[1,5-a]pyrimidine derivatives and their antifungal activities against phytopathogenic fungi in vitro.
    Zhang J; Peng JF; Bai YB; Wang P; Wang T; Gao JM; Zhang ZT
    Mol Divers; 2016 Nov; 20(4):887-896. PubMed ID: 27599494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of new imidazole, pyrimidine, and purine derivatives and analogs as inhibitors of xanthine oxidase.
    Biagi G; Costantini A; Costantino L; Giorgi I; Livi O; Pecorari P; Rinaldi M; Scartoni V
    J Med Chem; 1996 Jun; 39(13):2529-35. PubMed ID: 8691450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and optimization of pyrazolo[1,5-a]pyrimidines as new potent PDE4 inhibitors.
    Le Roux J; Leriche C; Chamiot-Clerc P; Feutrill J; Halley F; Papin D; Derimay N; Mugler C; Grépin C; Schio L
    Bioorg Med Chem Lett; 2016 Jan; 26(2):454-459. PubMed ID: 26681511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin.
    Krystof V; Moravcová D; Paprskárová M; Barbier P; Peyrot V; Hlobilková A; Havlícek L; Strnad M
    Eur J Med Chem; 2006 Dec; 41(12):1405-11. PubMed ID: 16996651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyrazolo[1,5-a]pyrimidines as estrogen receptor ligands: defining the orientation of a novel heterocyclic core.
    Compton DR; Carlson KE; Katzenellenbogen JA
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5681-4. PubMed ID: 15482947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzimidazole derivatives as potent inhibitors of milk xanthine oxidase.
    Rudnicka R; Bojarska E; Kazimierczuk Z
    Acta Pol Pharm; 2004 Dec; 61 Suppl():37-9. PubMed ID: 15909934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis of new derivatives of pyrazole and pyrazolo[3,4-d]pyrimidine].
    Machoń Z; Witkiewicz K
    Acta Pol Pharm; 1985; 42(6):516-20. PubMed ID: 3835811
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and antihypertensive activity of novel 1-(4-benzyl-1-phthalazinyl)-pyrazolo[3,4-d]pyrimidines.
    el-Feky SA; Abd el-Samii ZK
    Pharmazie; 1996 Aug; 51(8):540-3. PubMed ID: 8794464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.